Peptide guide

KLOW

A four-peptide blend — KPV, GHK-Cu, BPC-157, and TB-500 — sold for skin, gut, and soft-tissue recovery research.

KLOW is a single vial holding four separate peptides — KPV, GHK-Cu, BPC-157, and TB-500 — pitched as a one-shot recovery stack covering skin, gut, and connective tissue. None of the four is FDA-approved, the evidence behind each is mostly animal and lab work, and no published study has tested the four together as a blend. People run it stacked anyway, so the practical questions are how each piece works, how to handle a mixed vial that carries four molecules at four different amounts, and how not to get scammed buying it.

By the Zapify Research team

Reviewed against 11 clinical & research sources · Updated June 2026 · Educational use only

Type: 4-peptide blendKPV·GHK·BPC·TB
Route: Subcutaneousone daily shot
Typical dose: 250–750 mcg/daytotal blend
Cycle: 4–8 wks onthen a break
Storage: Mixed: 2–4 wksSealed: months
Status: Not FDA-approved

What is KLOW?

A single vial blending four peptides — KPV, GHK-Cu, BPC-157, and TB-500, often 80 mg with GHK-Cu at 50 mg — none FDA-approved and never tested together.

KLOW isn't one peptide. It's four of them combined in a single vial: KPV, GHK-Cu, BPC-157, and TB-500. The name is just the first letters rearranged. A common vial holds 80 mg split unevenly, with GHK-Cu at 50 mg and KPV, BPC-157, and TB-500 at 10 mg each, so the four don't sit at equal strength inside the mix.

Each peptide covers a different repair angle, and the pitch is that running them together hits skin, gut, and soft tissue at once. KPV is an anti-inflammatory tripeptide, a three-amino-acid fragment of the hormone alpha-MSH. GHK-Cu is a copper-bound tripeptide tied to collagen and skin repair. BPC-157 is a 15-amino-acid peptide studied for tendon, joint, and gut-lining healing. TB-500 is a thymosin beta-4 fragment studied for cell migration and soft-tissue recovery. The blend leans on each one's individual research; there's no separate body of evidence for the combination itself.

Because the components are sold and studied on their own, the deepest detail on any single one lives in its own guide. This page covers how they fit together, how the blended vial behaves, and the caveats that change once you're running all four at the same time.

None of the four peptides in KLOW is FDA-approved for anything, and the blend as a product has never been tested in a clinical trial. The evidence behind each component is overwhelmingly animal and cell-culture work, with little to no completed human data. Treat KLOW as an experimental research stack, not a proven medicine.

What is it studied for?

No study has tested the blend itself; "studied for" means each of the four peptides separately, almost all of it in animals and cell cultures.

No study has tested KLOW as a blend. What exists is the separate research behind each of the four peptides, almost all of it done in animals and cell cultures rather than people. So "studied for" here means "studied for, one component at a time, mostly in rats and dishes," and that distinction sits under everything the stack is marketed to do.

Evidence base, by subject

ManyAnimal & lab studies (across the four)

NoneHuman trials of the blend

Each peptide brings a different research focus to the stack:

Gut & inflammation (KPV)KPV is a fragment of alpha-MSH that calms inflammation by damping NF-κB signaling. In rodent colitis models it lowered inflammatory cytokines and helped the gut lining heal. Human data is still limited.

Skin & collagen (GHK-Cu)A copper tripeptide first isolated from human plasma in 1973. Animal and lab work ties it to collagen remodeling, wound closure, and new blood-vessel growth in skin.

Tissue repair (BPC-157 + TB-500)The recovery half of the stack. BPC-157's animal research clusters in tendon, joint, and gut tissue; TB-500's in cell migration and soft-tissue wound healing.

The mechanisms are partly understood and partly not. KPV's NF-κB inhibition and GHK-Cu's collagen and copper chemistry are reasonably well characterized in the lab. BPC-157 and TB-500 lean on angiogenesis and cell-migration ideas that make biological sense but aren't settled in humans. Whether the four interact usefully when injected together, or simply add up, is untested. The "synergy" language sellers use is a hypothesis, not a finding.

Why people use it

People run it to cover skin, gut, and connective tissue from one vial, though no human trial shows the blend delivers and fixed ratios can't be adjusted.

Most people who reach for KLOW want the convenience of one vial doing several jobs. These are the reasons they try it, not evidence that it delivers:

Wanting broad recovery across skin, gut, and connective tissue without running four separate vials and four separate draws.
A nagging soft-tissue injury alongside gut or skin issues, where no single peptide seems to cover the whole picture.
Gut inflammation specifically, where KPV's colitis research and BPC-157's gut-lining work are the draw.
Skin quality and healing, where GHK-Cu's collagen and copper research gets the attention.
The grind of hard training, and wanting a single recovery protocol rather than a shelf of vials.

No human trial has shown KLOW will do any of this, and the blend itself has never been studied. What's there is four peptides with individually coherent mechanisms, consistent animal signals, and mild reported side effects, packaged for convenience. The convenience is real, and so is the appeal of covering several repair pathways at once. But a blend also locks the four ratios together, so you can't adjust one component without changing the others. It won't replace the basics that actually have evidence behind them: rest, rehab, sleep, and loading tissue properly.

How to reconstitute KLOW

Mix the 80 mg blend with 3 mL bacteriostatic water for about 26.7 mg/mL, where 10 units on a U-100 syringe pulls all four peptides at once.

Your vial arrives as a single puck of dry powder holding all four peptides together. Mixing it into liquid is called reconstitution, and the steps are the same as any research peptide drawn for subcutaneous injection. The wrinkle with KLOW is that one draw pulls all four at once, in whatever ratio the vial was filled to, so you're dosing the blend as a unit rather than each peptide on its own.

Step 1Start with powderWipe the rubber stopper with an alcohol swab.

Step 2Add bac. waterRun it slowly down the inside wall — never shake.

Step 3Draw your doseThe calculator gives the exact units to draw to.

Wipe the rubber stopper with an alcohol swab first, every time.
Use bacteriostatic water, not plain sterile water and not saline. The trace of benzyl alcohol in it holds back bacteria, which matters because you'll be drawing from the same vial for weeks.
Add the water slowly, running it down the inside glass wall. Don't blast it straight onto the powder.
Don't shake it. Swirl gently and let it dissolve on its own. Shaking foams the solution and can damage the peptides; the copper in GHK-Cu also makes this mix more prone to foaming.

A common setup is an 80 mg blend vial (GHK-Cu 50 mg, plus KPV, BPC-157, and TB-500 at 10 mg each) mixed with 3 mL of bacteriostatic water, which gives roughly 26.7 mg/mL of total peptide. On a U-100 insulin syringe, 10 units is about 2.67 mg of blend, carrying all four components in their fixed proportions. The water doesn't change how much peptide is in the vial; it only sets the concentration, which decides how many units you draw under the skin. More water means a more dilute mix and a bigger draw for the same dose. You can't ruin it with too much or too little, you only change the draw math, and that's exactly what the calculator handles.

Calculate your exact KLOW reconstitution →

Dose & units

No dose is FDA-approved; reported use is 250–750 mcg of total blend daily, often one ~10-unit shot, cycled 4–8 weeks on with a 2–4 week break.

There is no FDA-approved dose for KLOW or for any of its four components. Everything below is a range that sellers and write-ups report, not a medical standard. Because it's a blend, dosing the stack means accepting whatever amount of each peptide the vial's ratios deliver; you can't dial one up without the others. Decide what goes into your body with a licensed provider, not with this page.

Typical range

Injected under the skin, the range reported most often is 250–750 mcg of total blend per day, commonly a once-daily subcutaneous shot of around 10 units on a U-100 syringe. That total splits across the four peptides by the vial's ratios, so most of it is GHK-Cu, with smaller shares of KPV, BPC-157, and TB-500.

Titration

Most write-ups start near the low end, around 250 mcg of blend a day for the first week, then move up if it's tolerated. Starting low lets you notice any reaction, including the warmth or flushing GHK-Cu can cause, before you've committed to more. There's no medal for starting high.

Cycling

Reported protocols treat this as a time-limited course rather than something you run forever, commonly 4–8 weeks on followed by a 2–4 week break. The whole stack runs as one subcutaneous injection, so all four peptides cycle together on the same schedule rather than being dosed on separate clocks.

On4–8 weeks

Off2–4 weeks

For the exact mark to draw to on your insulin syringe, don't eyeball it. The calculator turns your vial size, water, and target dose into the precise number of units, and with a four-peptide blend that math is easier to get wrong by hand.

Get your exact units →

Storage

Sealed powder lasts months at room temperature; once mixed, refrigerate at 2–8 °C and use within about 2–4 weeks, and a faint blue-green tint is normal from the copper.

Sealed & drySealed dry powder stays stable for months at room temperature and shrugs off shipping heat; freeze the unopened blend for longer holds.

ReconstitutedRefrigerate at 2–8 °C in the main compartment, use within about 2–4 weeks; don't freeze, keep out of light, and toss if cloudy.

You'll see longer windows quoted for peptide vials. Those figures are beyond-use dates for a sealed, unmixed vial that a compounding pharmacy has stability-tested, and they stop applying the moment you add water. A mixed vial runs on the shorter clock instead, because that's how long the preservative in bacteriostatic water reliably keeps the solution clean once you're drawing from it.

That two-to-four-week limit is about contamination, not potency; the peptides themselves often stay good well beyond it. Reconstitute with plain sterile water instead of bacteriostatic and you drop to a day or two, since there's no preservative holding bacteria back.

Don't freeze a reconstituted vial, keep it out of direct light, write the mix date on the label, and throw it out if the solution ever turns cloudy or discolored, whatever the date says. A faint blue-green tint is normal here, since the copper in GHK-Cu carries that color; cloudiness or particles are not.

Side effects & safety

Reported side effects are generally mild — injection-site irritation, GHK-Cu flushing and metallic taste — but there's no safety data on the blend, and BPC-157 and TB-500 are WADA-banned.

The reported side effects across the four peptides are generally mild. That picture comes from animal studies, scattered clinic observation, and user reports, not large human safety trials, and there's no safety data on the blend as a whole, so hold it loosely.

Most common: mild, short-lived redness or irritation at the injection site, sometimes more pronounced because the copper in GHK-Cu can sting going in.
GHK-Cu specifically: a warm flush across the face, neck, and chest within minutes, a brief metallic taste, and occasional mild headache in the first doses.
Less often: mild nausea (more associated with the BPC-157 component), brief fatigue or light-headedness early in a cycle, or temporary swelling at the site.

Talk to a doctor before starting if you have a history of cancer. The same new-blood-vessel and tissue-growth effects across these peptides that might help healing could, in theory, also feed tissue you don't want growing. That's unproven, but worth taking seriously. The same goes if you're pregnant, breastfeeding, on blood-pressure medication, or managing a serious health condition. Layering four active compounds at once also means more variables if something does go wrong.

If you compete, the blend is a problem because of what's in it. BPC-157 has been on the WADA banned list since 2022 (named under S0, non-approved substances), and TB-500, as thymosin beta-4 and its fragments, has been prohibited both in and out of competition since 2011. GHK-Cu is not currently on the WADA list and KPV's status is less clear, but two banned components are enough: using KLOW is a doping violation.

And the biggest risk here isn't really the molecules. It's whether the vial actually contains all four peptides, at the strengths on the label, in the ratios claimed. With a blend, that's four separate ways to be shorted in one purchase, and you can't see any of it in the powder. That comes down to where you buy it.

How to vet a source

Demand a third-party COA that breaks out all four peptides and their amounts separately, with a lot number matching your vial — not one combined figure or a screenshot.

This is an unregulated market, and a real share of independently tested vials come back underdosed, impure, or not even the compound on the label. A four-peptide blend multiplies that risk: a real certificate of analysis has to confirm each of the four peptides is present, correctly identified, and at the right amount, not just that something peptide-shaped is in the vial. The one document that separates a real seller from a gamble is that certificate: a third-party lab's report on what's actually inside.

A real COA shows

An identity test (usually mass spectrometry) confirming the peptide is what the label says.
A purity figure from HPLC, typically 98% or higher.
A lot or batch number that matches the number printed on your vial.
A named, independent accredited lab and a recent test date.

Walk away if

There’s no COA, or it’s a generic image with no lot number.
The “certificate” comes from the seller instead of a third-party lab.
The lot number doesn’t match your vial, or there isn’t one at all.
It’s a flat image you can’t trace back to the lab that issued it.

That's the standard worth holding any seller to, ours included. With a blend, push further: ask for a COA that breaks out all four peptides and their amounts, not a single combined figure. Match the lot number to your vial, and don't accept a screenshot in place of a traceable report.

See the Zapify compound catalog →

Common questions about KLOW

Is KLOW approved or proven to work?

No. None of its four peptides — KPV, GHK-Cu, BPC-157, or TB-500 — is FDA-approved for any use, and the blend itself has never been tested in a clinical trial. The evidence behind each component is almost entirely animal and cell-culture work, with little to no completed human data. The combination's marketed 'synergy' is a hypothesis, not a finding.

What's in KLOW, and in what amounts?

Four peptides in one vial. A common 80 mg version holds GHK-Cu at 50 mg, plus KPV, BPC-157, and TB-500 at 10 mg each. So GHK-Cu makes up most of the blend by weight, and every draw pulls all four in those fixed proportions. You can't adjust one without changing the others.

Why combine four peptides instead of running them separately?

Mostly convenience and a theory of overlapping repair. KPV targets inflammation, GHK-Cu skin and collagen, BPC-157 and TB-500 soft-tissue recovery, so a single vial is pitched as covering several pathways at once. The trade-off is control: a blend locks the ratios together, so you can't titrate one component or drop one that disagrees with you. Running them separately costs more vials and draws but lets you adjust each.

How is KLOW injected, and where on the body?

KLOW is reconstituted and drawn into a U-100 insulin syringe for a subcutaneous shot — into the fat just under the skin, commonly around the belly. One draw carries all four peptides in their fixed ratios, so the whole blend goes in as a single daily injection rather than four separate shots. Rotate the site to avoid irritation, and use the on-page calculator to turn your vial size and water into the exact number of units to draw.

Is KLOW banned for athletes?

Yes, because of its components. BPC-157 has been on the WADA banned list since 2022 and TB-500 (thymosin beta-4 and fragments) since 2011, prohibited both in and out of competition. GHK-Cu is not currently listed and KPV's status is less defined, but the two banned peptides make the blend a doping violation. Anyone competing should check the current WADA list directly.

Why bacteriostatic water and not saline or sterile water?

Because you'll be drawing from the same vial across weeks. Bacteriostatic water carries a trace of benzyl alcohol that holds back bacteria between draws; plain sterile water and saline have no preservative. On a multi-dose peptide vial — especially a blend you'll use daily — the professional sources all point the same way: bacteriostatic.

References

This page is for research and educational purposes only. It is not medical advice or a recommendation to use any compound. The dose ranges shown are reported by clinics and research literature, not validated medical standards, and KLOW is not FDA-approved. Talk to a licensed medical provider about anything you put in your body.